Indrani Lall Franchini

Companies

• Avanos MedicalBoard member Jul 3, 2024 to now¹
• Alnylam PharmaceuticalsGeneral counsel Feb 9, 2022 to Feb 29, 2024²
• Alexion PharmaceuticalsEVP, Chief Compliance Officer Jun 9, 2017 to Jul 23, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Alnylam Pharmaceuticals ALNY4,133 shares⁴$973.7K at $235.58Feb 28, 2024
• Avanos Medical AVNS0 shares⁵Jul 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 27, 2026Returned to company 4,817 shares at $25.00 of Avanos Medical⁵
• Jan 2, 2025Granted 12,003 shares of Avanos Medical⁶
• Feb 28, 2024Sold 1 shares at $158.09 of Alnylam Pharmaceuticals⁴
• Feb 28, 2024Sold 9 shares at $157.30 of Alnylam Pharmaceuticals⁴
• Feb 28, 2024Sold 66 shares at $156.38 of Alnylam Pharmaceuticals⁴
• Feb 28, 2024Sold 111 shares at $155.45 of Alnylam Pharmaceuticals⁴
• Feb 28, 2024Sold 142 shares at $154.54 of Alnylam Pharmaceuticals⁴
• Feb 27, 2024Exercised options 878 shares of Alnylam Pharmaceuticals⁴
• Feb 2, 2024Sold 269 shares at $172.38 of Alnylam Pharmaceuticals⁷
• Feb 2, 2024Sold 820 shares at $171.14 of Alnylam Pharmaceuticals⁷
• Feb 2, 2024Sold 502 shares at $170.01 of Alnylam Pharmaceuticals⁷
• Feb 1, 2024Exercised options 5,175 shares of Alnylam Pharmaceuticals⁷
• Apr 6, 2023Sold 3,500 shares at $210.00 of Alnylam Pharmaceuticals⁸
• Feb 2, 2023Sold 5 shares at $227.38 of Alnylam Pharmaceuticals⁹
• Feb 2, 2023Sold 586 shares at $226.62 of Alnylam Pharmaceuticals⁹
• Feb 2, 2023Sold 1,007 shares at $225.80 of Alnylam Pharmaceuticals⁹
• Feb 2, 2023Sold 77 shares at $223.97 of Alnylam Pharmaceuticals⁹
• Feb 1, 2023Exercised options 5,175 shares of Alnylam Pharmaceuticals⁹